Liquidity & Technical
Liquidity & Technical — Rashi Peripherals Ltd (RASHIPERIP)
Rashi Peripherals carries capacity-constrained liquidity: five-day trading depth at 20% ADV is ₹13.4 crore, making this a small-cap specialist name where position sizing governs implementation more than conviction does. The technical picture is unambiguously bullish — price is +43.6% above its 200-day SMA, a golden cross formed on 10 April 2026, and RSI has reached 77 — but the extreme short-term velocity (+43.8% in one month) and 30-day realized volatility at 42.8% demand respect for mean-reversion risk ahead of Q4 FY26 results on 14 May 2026.
1. Portfolio Implementation Verdict
5-Day Cap at 20% ADV (₹ Cr)
Largest 5d Position (% MCap)
Supported AUM at 5% Wt (₹ Cr)
ADV 20d (% Market Cap)
Tech Scorecard (+3 of +6)
Capacity-constrained. At 20% ADV participation, a fund clears only ₹13.4 crore in five days — supporting a 5% position for funds up to ₹268 crore. Any mandate above roughly ₹300 crore must build slowly over multiple weeks or treat this as watchlist-only. Tape is constructive but entry timing matters at RSI 77.
2. Price Snapshot
Price (₹)
YTD Return (%)
1-Year Return (%)
52w Position (0=Low, 100=High)
Beta
3. Full Price History with 50/200-Day SMA
Current price is above the 200-day SMA by 43.6%. This is a confirmed uptrend.
Golden cross on 10 April 2026. The 50-day SMA crossed above the 200-day SMA just four weeks ago, completing an extraordinary double-cross sequence: a death cross on 1 April 2026 was reversed in nine calendar days, signalling that the two SMAs were tightly compressed around ₹354-356 before the rally pulled the 50-day SMA sharply higher. The prior death cross on 27 December 2024 — aligned with the Q3 FY25 earnings collapse flagged in the Financials tab — correctly identified the worst phase of the drawdown.
The stock is in a confirmed uptrend from the IPO at ₹300 to a current all-time high at ₹530.6, broken by two corrective cycles (December 2024 and March-April 2026) that each resolved decisively to the upside.
4. Relative Strength vs Benchmark
No benchmark comparison available. RPTECH listed in February 2024, giving fewer than 28 months of price history. The INDA ETF (India broad-market benchmark) series cannot produce a meaningful 5-year relative performance comparison. Within its post-IPO window, RPTECH has returned +77.8% vs its IPO price — substantially outperforming the Nifty 50 over the same period — but the short history limits confidence in this alpha claim.
5. Momentum Panel — RSI and MACD
RSI(14) — Last 18 Months
RSI(14) at 77.2 is overbought (above 70). The directional signal is bullish — RSI rose from trough levels near 35 in the Q3 FY25 earnings shock to a post-IPO high — but 77 also marks the highest reading since listing, suggesting the stock is stretched on a 1-3 month horizon and vulnerable to a retracement if Q4 FY26 results disappoint.
MACD Histogram — Last 18 Months
The MACD histogram bottomed at −27.3 in April 2025 — coinciding with the price trough following Q3 FY25 results — and has recovered sharply to +3.02 currently. The positive and expanding histogram confirms near-term bullish momentum. The near-term risk is that histogram expansion is decelerating from the April 2026 peak surge, a condition that often precedes brief consolidation.
Near-term view (1-3 months): Momentum is bullish but overbought. RSI at 77 in a stock that has risen 43.8% in a month calls for patience on entry rather than chase. A pullback to the ₹460-480 zone would offer a better risk-reward entry into what is otherwise a confirmed uptrend.
6. Volume, Volatility, and Sponsorship
Volume — Last 12 Months
Top Volume-Spike Days
All three highest-volume sessions of the past year closed positive — a clear sign of institutional accumulation rather than distribution. The 24 March session (5.67x average volume, intraday range ₹341-363) with a modest net gain of just 1.01% is the tell: someone took delivery of significant size at these prices without driving the close. The April-May volume run-rate of 300,000-350,000 shares daily is running 35-40% above the 60-day ADV of 184,132, confirming that new buyers are entering the order book.
30-Day Realized Volatility — Post-IPO History
Volatility bands from historical data: calm = below 1.69% (p20), normal = 1.69-13.63% (p20-p80), stressed = above 13.63% (p80). Current realized vol at 42.84% — near the post-IPO maximum of 44.55% — is extreme by this stock's own history. The market is demanding a wider risk premium, and large-order execution will carry meaningfully higher impact cost than the quiet 2024-2025 period.
7. Institutional Liquidity Panel
Market cap and shares outstanding data were not available in the automated liquidity feed; capacity figures below are estimated using ₹34,966 Mn market cap from company data. All runway figures are indicative.
A. ADV and Turnover Strip
ADV 20d (Shares)
ADV 20d (₹ Crore)
ADV 60d (Shares)
ADV 20d (% Market Cap)
Annual share turnover not available in the data feed.
B. Fund-Capacity Table
C. Liquidation Runway (Estimated from ₹34,966 Mn Market Cap)
Execution friction: Median daily intraday range over the last 60 days is 3.88% — elevated above the 2% threshold that signals meaningful bid-ask cost for large orders. At current volatility levels, institutional execution on even a 0.5% market-cap position will incur non-trivial market impact.
The largest position that clears in five trading days at 20% ADV participation is approximately 0.38% of market cap (₹13.4 crore). At the more conservative 10% ADV rate, five-day capacity drops to ₹6.7 crore (0.19% of market cap).
8. Technical Scorecard and Stance
Total score: +3 out of +6 — Bullish.
The tape is telling a story that the Financials tab validates: RPTECH's Q3 FY26 EBITDA recovery from ₹17 crore (Q3 FY25 disaster) to ₹119 crore is a step-change the market is repricing aggressively. Every high-volume session since 24 March 2026 has closed in the upper half of its daily range — institutional accumulation, not distribution. The golden cross on 10 April was confirmed by follow-through volume; the stock has not closed below the April 10 golden-cross level (₹405) since it was struck. Q4 FY26 results are due on 14 May 2026 — six days from the date of this report — and the 43.8% one-month move suggests those expectations are already elevated. RSI divergence or post-results selling below ₹450 would be the key invalidation signal to monitor.
Bull confirmation above ₹600: A sustained daily close above ₹600 (+13% from current) on above-average volume would confirm the market is pricing growth acceleration beyond the FY26 margin recovery — the right condition to add to an existing position.
Bear invalidation below ₹450: A close below ₹450 (near the post-golden-cross consolidation lows; 20-day SMA at ₹467 is the first dynamic support) would signal that Q4 FY26 results have disappointed or the current rally was entirely pre-announcement speculation. The 50-day SMA at ₹399 is the structural backstop.
Liquidity is the constraint. At ₹13.4 crore five-day capacity at 20% ADV, this stock is implementable only for small-cap specialist funds or India micro-cap mandates with AUM below ₹268 crore at a 5% position weight. For larger funds, the correct action is to build slowly over 4-6 weeks, targeting no more than 10-15% ADV daily participation to avoid self-inflicted impact cost. Do not chase this move into results.